JANX007 Clinical Trials (2026): 1 Studies for Castration Resistant Prostatic Cancer & Metastatic Castration-resistant Prostate Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 JANX007 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Castration Resistant Prostatic Cancer & Metastatic Castration-resistant Prostate Cancer) and 272 total planned enrollment. 1 JANX007 clinical trial is actively recruiting at 30 U.S. sites across 17 states. Most recent activity: NCT05519449 (Dec 2028).
Where to Participate: All JANX007 Trial Sites in the U.S. (30 sites across 17 states)
Every actively recruiting JANX007trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AL | University of Alabama at Birmingham Hospital | Birmingham35249 | NCT05519449 | Map |
| AZ | Mayo Clinic | Phoenix85054 | NCT05519449 | Map |
| CA | UCLA Department of Medicine | Los Angeles90095 | NCT05519449 | Map |
| CA | USC Norris Comprehensive Cancer Center | Los Angeles90033 | NCT05519449 | Map |
| CA | Hoag Memorial Hospital Presbyterian | Newport Beach92663 | NCT05519449 | Map |
| CA | University of California Davis Comprehensive Cancer Center | Sacramento95817 | NCT05519449 | Map |
| CA | UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco94158 | NCT05519449 | Map |
| CT | Yale New Haven Hospital | New Haven06510 | NCT05519449 | Map |
| FL | Mayo Clinic | Jacksonville32224 | NCT05519449 | Map |
| IL | University of Chicago Medical Center | Chicago60637 | NCT05519449 | Map |
| MD | University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore21201 | NCT05519449 | Map |
| MN | University of Minnesota Medical Center | Minneapolis55455 | NCT05519449 | Map |
| MN | Mayo Clinic | Rochester55905 | NCT05519449 | Map |
| MO | Washington University School of Medicine | St Louis63110 | NCT05519449 | Map |
| NY | Northwell Health R.J. Zuckerberg Cancer Hospital | Lake Success11042 | NCT05519449 | Map |
| NY | Memorial Sloan Kettering Cancer Center | New York10065 | NCT05519449 | Map |
| NY | Weill Cornell Medicine | New York10065 | NCT05519449 | Map |
| NY | Montefiore Medical Center | The Bronx10461 | NCT05519449 | Map |
| OH | University of Cincinnati Medical Center | Cincinnati45267 | NCT05519449 | Map |
| PA | Penn State Milton S. Hershey Medical Center | Hershey17033 | NCT05519449 | Map |
| PA | Thomas Jefferson University Honickman Center | Philadelphia19107 | NCT05519449 | Map |
| PA | UPMC Hillman Cancer Center | Pittsburgh15232 | NCT05519449 | Map |
| RI | Rhode Island Hospital | Providence02903 | NCT05519449 | Map |
| SC | Medical University of South Carolina | Charleston29425 | NCT05519449 | Map |
| TN | Sarah Cannon Research | Nashville37203 | NCT05519449 | Map |
| TX | Mary Crowley Cancer Research | Dallas75230 | NCT05519449 | Map |
| TX | University of Texas Southwestern Medical Center | Dallas75390 | NCT05519449 | Map |
| TX | Houston Methodist Hospital | Houston77030 | NCT05519449 | Map |
| WI | University of Wisconsin Carbone Cancer Center | Madison53792 | NCT05519449 | Map |
| WI | Froedtert Hospital and the Medical College of Wisconsin | Milwaukee53226 | NCT05519449 | Map |
JANX007 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting JANX007 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT05519449 | ENGAGER-PSMA-01Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) | P1 | Prostate Cancer | 272 | Sep 2022 |
All JANX007 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT05519449 | ENGAGER-PSMA-01 | Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) | P1 | recruiting | 272 | Janux Therapeutics | Sep 2022 |
JANX007 clinical trials: frequently asked questions
- How many JANX007 clinical trials are there?
- 1 JANX007 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are JANX007 clinical trials recruiting in 2026?
- Yes — 1 JANX007 trial is actively recruiting in 2026, with 30 U.S. sites across 17 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is JANX007 being studied for?
- JANX007 is being studied for Castration Resistant Prostatic Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer. The trials are grouped by indication on this page.
- What phase is JANX007 in?
- JANX007 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors JANX007 clinical trials?
- The lead sponsor across the most JANX007 trials is Janux Therapeutics. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming JANX007as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: